Clinical trial
MyomaS Aspect Transformation at Ultrasound During Relugolix Estradiol Noretisterone Treatment: MySaturn Study
NCT06953076 is registered in ClinicalTrials.gov with Fondazione Policlinico Universitario Agostino Gemelli IRCCS as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MyomaS Aspect Transformation at Ultrasound During Relugolix Estradiol Noretisterone Treatment: MySaturn Study
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- May 2, 2025
- Completion date
- May 2, 2027
- Enrollment
- 111 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
uterine bleeding, uterine hemorrhage, uterine leiomyomas, uterine neoplasms